Hong Yang

Dr. Hong Yang

Auto-generated profile, based on publicly available information

Dr. Hong Yang


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2008 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
ZGZhongMao Guo
ZhongMao Guo
QRQitao Ran
Qitao Ran
LRL. Jackson Roberts
L. Jackson Roberts
LZLichun Zhou
Lichun Zhou
ARArlan Richardson
Arlan Richardson
HYHong Yang
Hong Yang

1 November 2009 in Atherosclerosis
Verified
Journal Article
Closed access
HYHong Yang
Hong Yang
LZLiChun Zhou
LiChun Zhou
ZWZefen Wang
Zefen Wang
LRL. Jackson Roberts
L. Jackson Roberts
XLXinghua Lin
Xinghua Lin
ZGzhongmao Guo
zhongmao Guo

1 June 2009 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
OOOgbeyalu E. Onumah
Ogbeyalu E. Onumah
GJGeorge E. Jules
George E. Jules
YZYanfeng Zhao
Yanfeng Zhao
LZLiChun Zhou
LiChun Zhou
HYHong Yang
Hong Yang
ZGzhongmao Guo
zhongmao Guo

1 February 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
XCXinping Chen
Xinping Chen
ZGZhongmao Guo
Zhongmao Guo
EOEmmanuel U. Okoro
Emmanuel U. Okoro
HZHongfeng Zhang
Hongfeng Zhang
LZLiChun Zhou
LiChun Zhou
HYHong Yang
Hong Yang
Activation of very low density lipoprotein receptor (VLDLR) and apolipoprotein E receptor 2 (apoER2) results in either pro- or anti-atherogenic effects depending on the ligand. Using reelin and apoE as ligands, we studied the impact of VLDLR- and apoER2-mediated signaling on the expression of ATP binding cassette transporter A1 (ABCA1) and cholesterol efflux using RAW264.7 cells. Treatment of these mouse macrophages with reelin or human apoE3 significantly increased ABCA1 mRNA and protein levels, and apoAI-mediated cholesterol efflux. In addition, both reelin and apoE3 significantly increased phosphorylated disabled-1 (Dab1), phosphatidylinositol 3-kinase (PI3K), protein kinase Cζ (PKCζ), and specificity protein 1 (Sp1). This reelin- or apoER2-mediated up-regulation of ABCA1 expression was suppressed by 1) knockdown of Dab1, VLDLR, and apoER2 with small interfering RNAs (siRNAs), 2) inhibition of PI3K and PKC with kinase inhibitors, 3) overexpression of kinase-dead PKCζ, and 4) inhibition of Sp1 DNA binding with mithramycin A. Activation of the Dab1-PI3K signaling pathway has been implicated in VLDLR- and apoER2-mediated cellular functions, whereas the PI3K-PKCζ-Sp1 signaling cascade has been implicated in the regulation of ABCA1 expression induced by apoE/apoB-carrying lipoproteins. Taken together, these data support a model in which activation of VLDLR and apoER2 by reelin and apoE induces ABCA1 expression and cholesterol efflux via a Dab1-PI3K-PKCζ-Sp1 signaling cascade.

1 March 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
XCXinping Chen
Xinping Chen
YZYanfeng Zhao
Yanfeng Zhao
ZGZhongmao Guo
Zhongmao Guo
LZLichun Zhou
Lichun Zhou
EOEmmanuel U. Okoro
Emmanuel U. Okoro
HYHong Yang
Hong Yang
ATP-binding cassette transporter A1 (ABCA1) is a membrane-bound protein that regulates the efflux of cholesterol derived from internalized lipoproteins. Using a mouse macrophage cell line, this report studied the impact of low-density lipoproteins (LDL) on ABCA1 expression and the signaling pathway responsible for lipoprotein-induced ABCA1 expression. Our data demonstrated that treatment of macrophages with LDL increased ABCA1 mRNA and protein levels 4.3- and 3.5-fold, respectively. LDL also induced an ∼2-fold increase in macrophage surface expression of ABCA1 and a 14-fold-increase in apolipoprotein AI-mediated cholesterol efflux. In addition, LDL significantly increased the level of phosphorylated specificity protein 1 (Sp1) and the amount of Sp1 bound to the ABCA1 promoter without alteration in total Sp1 protein level. Mutation of the Sp1 binding site in the ABCA1 promoter and inhibition of Sp1 DNA binding with mithramycin A suppressed the ABCA1 promoter activity and reduced the ABCA1 expression level induced by LDL. LDL treatment also elevated protein kinase C-ζ (PKC-ζ) phosphorylation and induced PKC-ζ binding with Sp1. Inhibition of PKC-ζ with kinase inhibitors or overexpression of kinase-dead PKC-ζ attenuated Sp1 phosphorylation and ABCA1 expression induced by LDL. These results demonstrate for the first time that activation of the PKCζ-Sp1 signaling cascade is a mechanism for regulation of LDL-induced ABCA1 expression.

1 October 2009 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
ZWZefen Wang
Zefen Wang
HYHong Yang
Hong Yang
Aramandla RameshAramandla Ramesh
Aramandla Ramesh
LRL. Jackson Roberts
L. Jackson Roberts
LZLiChun Zhou
LiChun Zhou
ZGzhongmao Guo
zhongmao Guo